CA Patent

CA3191598A1 — Novel jak inhibitor compounds, method for synthesizing same and use thereof

Assigned to Galderma Holding SA · Expires 2022-03-17 · 4y expired

What this patent protects

Novel compounds having formula (I) and methods of using these compounds to treat diseases, conditions, and disorders are described.

USPTO Abstract

Novel compounds having formula (I) and methods of using these compounds to treat diseases, conditions, and disorders are described.

Drugs covered by this patent

Patent Metadata

Patent number
CA3191598A1
Jurisdiction
CA
Classification
—
Expires
2022-03-17
Drug substance claim
No
Drug product claim
No
Assignee
Galderma Holding SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.